Dechra Pharmaceuticals PLC/ GB0009633180 /
6/1/2023 5:29:50 PM | Chg. +2.00 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3,361.00GBX | +0.06% | 123,087 Turnover(GBP): 4.22 mill. |
-Bid Size: - | -Ask Size: - | 3.64 bill.GBP | - | - |
Assets
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 16.1000 | 18.3000 | 16.8000 | 37.7000 | 45.2000 | ||||||
Intangible Assets | 219.6000 | 196.2000 | 166.7000 | 360.4000 | 396.3000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 10.9000 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 29.2000 | 29.7000 | 31.7000 | 54.4000 | 56.5000 | ||||||
Accounts Receivable | 25.3000 | 28.3000 | 27.7000 | 59.2000 | 59.7000 | ||||||
Cash and Cash Equivalents | 32.8000 | 26.8000 | 45.9000 | 39.1000 | 61.2000 | ||||||
Current Assets | 179.5000 | 86.3000 | 108.6000 | 162.5000 | 185 | ||||||
Total Assets | 415.1000 | 300.8000 | 292.1000 | 560.8000 | 638.1000 |
Liabilities
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 11.9000 | 12.9000 | 10.4000 | 24.3000 | 21.4000 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 37.6000 | 28 | 25 | 60.8000 | 55 | ||||||
Liabilities | 240.5000 | 96 | 97.6000 | 284.1000 | 335.4000 | ||||||
Share Capital | .8720 | .8770 | .8800 | .9270 | .9320 | ||||||
Total Equity | 174.6000 | 204.8000 | 194.5000 | 276.6000 | 302.6000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 2 | 1.6000 | ||||||
Total liabilities equity | 415.1000 | 300.8000 | 292.1000 | 560.8000 | 638.1000 |
Income Statement
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 189.2000 | 193.6000 | 203.5000 | 247.6000 | 359.3000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 18.3000 | 25 | 26 | 19.5000 | 33.2000 | ||||||
Interest Income | -5.8000 | -3.6000 | -.2000 | -4.9800 | -4.5000 | ||||||
Income Before Taxes | 12.5000 | 21.4000 | 25.8000 | 14.5000 | 28.6000 | ||||||
Income Taxes | 1.6000 | 2 | 6.3000 | 2 | 2.5000 | ||||||
Minority Interests Profit | 7.1000 | 39.6000 | 0.0000 | -.2000 | .0050 | ||||||
Net Income | 17.9000 | 59.1000 | 19.5000 | 12.5000 | 26.1000 |
Per Share
Cash Flow
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 36.9000 | 11.5000 | 41 | 43.6000 | 77.4000 | ||||||
Cash Flow from Investing Activities | -19.4000 | 76.6000 | -4.7000 | -174 | -57.3000 | ||||||
Cash Flow from Financing | -18.3000 | -92.1000 | -14.8000 | 125.3000 | 1.6000 | ||||||
Decrease / Increase in Cash | 1.1000 | -1.9000 | -2.3000 | -5.1000 | 21.7000 | ||||||
Employees | 1,287 | 828 | 863 | 1,308 | 1,338 |